51. Discovery of potent non-urea inhibitors of soluble epoxide hydrolase
- Author
-
Christophe Morisseau, Yidong Liu, Fang Yan, Donald W. Landry, Bruce D. Hammock, Caty Chung, Shi Xian Deng, Xiangpo Li, Lars Branden, Gangli Gong, Yan Feng, Deborah H. Smith, Zhengxiang Zhu, Dusica Vidovic, Alison Rinderspacher, Stephan C. Schürer, and Yuli Xie
- Subjects
Epoxide hydrolase 2 ,High-throughput screening ,Clinical Biochemistry ,Pharmaceutical Science ,Biochemistry ,Chemical synthesis ,Article ,Structure-Activity Relationship ,Drug Discovery ,Structure–activity relationship ,Humans ,Urea ,Molecular Biology ,chemistry.chemical_classification ,Epoxide Hydrolases ,biology ,Chemistry ,Drug discovery ,Organic Chemistry ,Enzyme ,Solubility ,Enzyme inhibitor ,biology.protein ,cardiovascular system ,Molecular Medicine - Abstract
Soluble epoxide hydrolase (sEH) is a novel target for the treatment of hypertension and vascular inflammation. A new class of potent non-urea sEH inhibitors was identified via high throughput screening (HTS) and chemical modification. IC(50)s of the most potent compounds range from micromolar to low nanomolar.
- Published
- 2008